JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB91606

Anti-Lysophospholipase 1/LPL-I antibody [EPR3667]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

5

(1 Review)

|

(21 Publications)

Rabbit Recombinant Monoclonal Lysophospholipase 1/LPL-I antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 21 publications.

View Alternative Names

APT1, LPL1, LYPLA1, Acyl-protein thioesterase 1, APT-1, hAPT1, Lysophospholipase 1, Lysophospholipase I, Palmitoyl-protein hydrolase, LPL-I, LysoPLA I

5 Images
Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)
  • WB

Lab

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)

Lanes 1- 2 : Merged signal (red and green). Green - ab91606 observed at 25 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab91606 was shown to react with Lysophospholipase 1/LPL-I in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266195 (knockout cell lysate ab257509) was used. Wild-type HEK-293T and LYPLA1 knockout HEK-293T cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab91606 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 5000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (ab91606) at 1/5000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

LYPLA1 knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human LYPLA1 (Lysophospholipase 1/LPL-I) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-lypla1-lysophospholipase-1-lpl-i-knockout-hek-293t-cell-line-ab266195'>ab266195</a>)

Predicted band size: 25 kDa

Observed band size: 25 kDa

false

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)
  • WB

Lab

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)

Lane 1 : Wild-type HAP1 whole cell lysate (40 μg)
Lane 2 : LYPLA1 knockout HAP1 whole cell lysate (40 μg)
Lanes 1 - 2 : Merged signal (red and green). Green - ab91606 observed at 25 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab91606 was shown to specifically react with LYPLA1 in wild-type HAP1 cells. No band was obsereved when LYPLA1 knockout samples were examined. Wild-type and LYPLA1 knockout samples were subjected to SDS-PAGE. ab91606 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/5000 dilution and 1/10,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (ab91606)

Predicted band size: 25 kDa

false

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)
  • WB

Unknown

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)

All lanes:

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (ab91606) at 1/5000 dilution

Lane 1:

Fetal liver tissue lysate at 10 µg

Lane 2:

Fetal heart tissue lysate at 10 µg

Lane 3:

Human spleen tissue lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit IgG at 1/1000 dilution

Predicted band size: 25 kDa

false

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)
  • WB

Lab

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)

All lanes:

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (ab91606) at 1/5000 dilution

Lane 1:

Human liver tissue lysates at 20 µg

Lane 2:

Human fetal heart tissue lysates at 20 µg

Lane 3:

Mouse liver tissue lysates at 20 µg

Lane 4:

Rat liver tissue lysates at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 25 kDa

Observed band size: 25 kDa

false

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)
  • WB

Unknown

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (AB91606)

All lanes:

Western blot - Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] (ab91606) at 1/5000 dilution

Lane 1:

Mouse heart lysate at 10 µg

Lane 2:

Mouse kidney lysate at 10 µg

Lane 3:

Mouse spleen lysate at 10 µg

Lane 4:

Rat kidney lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit IgG at 1/1000 dilution

Predicted band size: 25 kDa

false

  • Carrier free

    Anti-Lysophospholipase 1/LPL-I antibody [EPR3667] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3667

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/500 - 1/1000", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/20000", "WB-species-notes": "<p></p>" }, "Mouse": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/500 - 1/1000", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/20000", "WB-species-notes": "<p></p>" }, "Rat": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/500 - 1/1000", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/20000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Lysophospholipase 1 also known as LPL-I is an enzyme involved in lipid metabolism. It catalyzes the hydrolysis of lysophospholipids into fatty acids and glycerophospholipids. The molecular mass of Lysophospholipase 1 is approximately 25 kDa. This protein is expressed in various tissues including heart liver and brain. Alternate names for this enzyme include APEH and acylaminoacyl-peptidase reflecting its ability to hydrolyze peptides and acyl groups.
Biological function summary

Lysophospholipase 1 plays a role in maintaining lipid homeostasis. It does not function as part of a larger protein complex acting independently in the regulation of lipid turnover. By breaking down lysophospholipids the enzyme helps balance the cellular lipid composition ensuring proper membrane integrity and cellular signaling. This regulation is critical in tissues that have high turnover of lipids like the brain and liver.

Pathways

Lysophospholipase 1 participates in lipid metabolism and glycerophospholipid biosynthesis pathways. The enzyme helps process intermediates in these pathways facilitating energy production and phospholipid remodeling. In terms of related proteins LPL-I functions in coordination with phospholipase A2 in lipid degradation and this relationship impacts the synthesis of bioactive lipid mediators.

Lysophospholipase 1 has been linked to metabolic disorders and neurological diseases. Altered activity of this enzyme has correlations with conditions such as metabolic syndrome where lipid imbalances occur. Moreover its dysregulation can influence neurological disorders like Alzheimer's Disease due to its impact on lipid signaling. In these contexts LPL-I interacts functionally with other enzymes like phospholipase A2 which also plays a role in lipid signaling and homeostasis.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as an acyl-protein thioesterase (PubMed : 19439193, PubMed : 20418879). Hydrolyzes fatty acids from S-acylated cysteine residues in proteins such as trimeric G alpha proteins or HRAS (PubMed : 20418879). Acts as a palmitoyl thioesterase that catalyzes depalmitoylation of proteins, such as ADRB2, KCNMA1 and SQSTM1 (PubMed : 22399288, PubMed : 27481942, PubMed : 37802024). Acts as a negative regulator of autophagy by mediating palmitoylation of SQSTM1, decreasing affinity between SQSTM1 and ATG8 proteins and recruitment of ubiquitinated cargo proteins to autophagosomes (PubMed : 37802024). Acts as a lysophospholipase and hydrolyzes lysophosphatidylcholine (lyso-PC) (PubMed : 19439193). Also hydrolyzes lysophosphatidylethanolamine (lyso-PE), lysophosphatidylinositol (lyso-PI) and lysophosphatidylserine (lyso-PS) (By similarity). Has much higher thioesterase activity than lysophospholipase activity (PubMed : 19439193). Contributes to the production of lysophosphatidic acid (LPA) during blood coagulation by recognizing and cleaving plasma phospholipids to generate lysophospholipids which in turn act as substrates for ENPP2 to produce LPA (PubMed : 21393252).
See full target information LYPLA1

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 8:477 PubMed40121269

2025

ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Guo,Zhiqing Lin,Di Zhang,Qilong Qin,Zewen Li,Yuqing Yin,Jiangfan Chen,Wei Guo

Cell death & disease 15:674 PubMed39277582

2024

Impaired SUMOylation of FoxA1 promotes nonalcoholic fatty liver disease through down-regulation of Sirt6.

Applications

Unspecified application

Species

Unspecified reactive species

Dongmei Zou,Jinwen Liao,Min Xiao,Liang Liu,Dongling Dai,Mingguo Xu

Aging 15:9499-9520 PubMed37751585

2023

M2 macrophage-derived exosomal miR-486-5p influences the differentiation potential of bone marrow mesenchymal stem cells and osteoporosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jincheng Liu,Zhenqian Sun,Yunhao You,Lu Zhang,Dehui Hou,Guanghui Gu,Yunzhen Chen,Guangjun Jiao

Regenerative therapy 24:351-360 PubMed37674692

2023

Acyl-protein thioesterase1 alleviates senile osteoporosis by promoting osteoblast differentiation via depalmitoylation of BMPR1a.

Applications

Unspecified application

Species

Unspecified reactive species

Changjiao Ji,Qiaoyan Dong,Huihui Liu,Xiaodeng Yang,Yingguang Han,Bingrui Zhu,Huaixin Xing

Reproductive sciences (Thousand Oaks, Calif.) 31:128-138 PubMed37603234

2023

Estrogen Regulates Scribble Localization in Endometrial Epithelial Cells Through Acyl Protein Thioesterase (APT)-Mediated S-Palmitoylation in Adenomyosis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhixing Jin,Juan Wang,Youguo Chen

Frontiers in pharmacology 14:1124633 PubMed37251330

2023

PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM.

Applications

Unspecified application

Species

Unspecified reactive species

Yapeng Liu,Lu Han,Ping Zhu,Ming Song,Yaoyuan Zhang,Linlin Meng,Wei Zhang,Cheng Zhang,Ming Zhong

Stem cells translational medicine 12:307-321 PubMed37010483

2023

WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jincheng Liu,Yunhao You,Zhenqian Sun,Lu Zhang,Xiang Li,Zihan Dai,Jinlong Ma,Yunzhen Chen,Guangjun Jiao

Scientific reports 13:2933 PubMed36806358

2023

Molecular mechanism of valine and its metabolite in improving triglyceride synthesis of porcine intestinal epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Mengmeng Xu,Long Che,Lizhu Niu,Liuzhen Wang,Mengyun Li,Dongfeng Jiang,Hongyu Deng,Wen Chen,Zongyong Jiang

Cell metabolism 35:332-344.e7 PubMed36634673

2023

Palmitoylation couples insulin hypersecretion with β cell failure in diabetes.

Applications

Unspecified application

Species

Unspecified reactive species

Guifang Dong,Sangeeta Adak,George Spyropoulos,Qiang Zhang,Chu Feng,Li Yin,Sarah L Speck,Zeenat Shyr,Shuntaro Morikawa,Rie Asada Kitamura,Rahul S Kathayat,Bryan C Dickinson,Xue Wen Ng,David W Piston,Fumihiko Urano,Maria S Remedi,Xiaochao Wei,Clay F Semenkovich

iScience 25:104996 PubMed36105595

2022

Activity-based protein profiling of human and serine hydrolases and interrogation of potential antimalarial targets.

Applications

Unspecified application

Species

Unspecified reactive species

Dara Davison,Steven Howell,Ambrosius P Snijders,Edgar Deu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com